Related Experiment Video

Updated: Jun 26, 2026

Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos
13:59

Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos

Published on: June 14, 2012

CK2beta interacts with and regulates p21-activated kinases in Drosophila

Benjamin Mentzel1, Eike Jauch, Thomas Raabe

  • 1University of Würzburg, Institut für Medizinische Strahlenkunde und Zellforschung, Versbacherstr. 5, D-97078 Würzburg, Germany.

Biochemical and Biophysical Research Communications
|January 6, 2009
PubMed

Insights

The regulatory subunit CK2beta interacts with p21-activated kinase (PAK) proteins independently of CK2alpha. This interaction negatively regulates PAK kinase activity, revealing new functions for CK2beta outside its known holoenzyme complex.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Signaling

Background:

  • Protein kinase CK2 is a heterotetrameric complex with CK2beta as its regulatory subunit.
  • CK2beta has been found to interact with other kinases, suggesting roles beyond the CK2 holoenzyme.
  • Previous research identified interactions between CK2beta and kinases like A-Raf, Chk1, and c-Mos.

Purpose of the Study:

  • To investigate the interaction of Drosophila CK2beta with p21-activated kinase (PAK) proteins outside the CK2 holoenzyme.
  • To determine if CK2beta can regulate PAK kinase activity independently of CK2alpha.

Main Methods:

  • Co-immunoprecipitation assays to detect protein interactions.
  • Analysis of specific isoforms of Drosophila PAK and CK2beta.
  • Biochemical assays to assess kinase activity regulation.

Main Results:

  • The study identified the first interaction between Drosophila CK2beta and PAK proteins outside the CK2 holoenzyme.
  • Distinct isoforms of PAK and CK2beta were observed to interact.
  • CK2beta binding to PAK proteins does not require CK2beta subunit dimerization, unlike the CK2alpha-CK2beta interaction.
  • CK2beta negatively regulates PAK kinase activity in a CK2alpha-independent manner.

Conclusions:

  • CK2beta possesses functions independent of the CK2 holoenzyme, interacting with PAK proteins.
  • The interaction between CK2beta and PAK proteins is isoform-specific and does not require CK2beta dimerization.
  • CK2beta acts as a negative regulator of PAK kinase activity, highlighting a novel signaling pathway.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...